IQVIA Holdings Inc (IQV)

Over the past six months, IQVIA's stock has experienced some fluctuations. As of October 3, 2025, the stock price was $206.63, representing a decline of 10.10% compared to October 4, 2024. Key events impacting the stock include Q2 2025 earnings where IQVIA reported its second-quarter profit and revenue above Wall Street expectations, driven by increased demand for its healthcare data and analytics services, leading to an approximate 8% rise in shares in premarket trading. IQVIA is scheduled to announce its third-quarter 2025 results on October 28, 2025. Investor sentiment improved as the stock rose 16% by October 2, 2025, and analysts have a "Strong Buy" consensus rating for IQV stock.

While specific seasonal patterns for IQVIA's products and services are not explicitly detailed, the company has demonstrated resilient demand for healthcare analytics and durable customer demand for its services, suggesting a relatively consistent demand throughout the year rather than pronounced seasonality. The company's focus on essential services for the life sciences industry implies a steady need for its offerings regardless of the calendar quarter.

IQVIA Holdings, Inc. is a global leader in health information technology and clinical research within the Healthcare sector, specifically in the Life Sciences Tools and Services industry, providing advanced analytics, technology solutions, and clinical research services. The company's major products and services are categorized into three segments: Technology & Analytics Solutions (TAS) which offers information, cloud-based applications, real-world solutions, market measurement, customer engagement solutions, data management, and consulting services; Research & Development Solutions (R&DS) which provides outsourced clinical research and clinical trial-related services; and Contract Sales & Medical Solutions which delivers healthcare provider and patient engagement services, as well as scientific strategy and medical affairs services.

IQVIA Holdings, Inc. has a significant global presence, with operations in over 100 countries across Asia, Europe, the Americas, and Africa. The company's headquarters are located in Durham, North Carolina, U.S.

IQVIA has maintained a strong brand reputation over the past year and was named #1 in its category on the Fortune® World's Most Admired Companies™ list for the fourth consecutive year. The company ranked number one in categories such as innovation, global competitiveness, people management, and use of corporate assets. No significant negative events affecting IQVIA's reputation in the past year were identified.

IQVIA Holdings Inc. operates with a dispersed ownership structure, primarily held by major institutional investors, who hold approximately 82.46% of the company's stock. Major institutional owners include The Vanguard Group, Inc., BlackRock, Inc., Harris Associates L.P., State Street Global Advisors, Inc., Geode Capital Management, LLC, Canada Pension Plan Investment Board, Farallon Capital Management, L.L.C., AllianceBernstein L.P., Artisan Partners Limited Partnership and JPMorgan Chase & Co.. Individual investors and public companies hold approximately 16.65% of the stock, while insiders own about 0.89%.